Markets / IPO / Accretion Pharmaceuticals

Accretion Pharmaceuticals IPO

Updated 01:57

SME IPO on NSE Emerge · Pharmaceuticals

Status

Listed

Price band

₹96–101

Lot size

1200 shares · ₹1,21,200

Subscribed

–

How it listed

Issue price

₹101

Listing price (open)

₹79.00 -21.78%

First-day close

₹82.95 -17.87%

Price now

₹202.50 +100.50%

Listing day	21 May 2025
Open / high / low / close	₹79.00 / ₹82.95 / ₹75.05 / ₹82.95
Shares traded on NSE	6,58,800
Market value at the listing-day close	₹92 cr

Closing prices since listing: 26 Oct ₹186.00, 27 Oct ₹185.00, 28 Oct ₹185.00, 29 Oct ₹181.00, 30 Oct ₹190.05, 2 Nov ₹199.55, 3 Nov ₹209.50, 4 Nov ₹206.00, 5 Nov ₹212.00, 6 Nov ₹202.05.

Accretion Pharmaceuticals share price, live chart and technicals →

Key dates

Bidding opens	14 May 2025
Bidding closes	16 May 2025
Allotment	19 May 2025
Refunds and shares in demat	20 May 2025
Listing	21 May 2025

Lot size by investor type

Application	Lots	Shares	Amount
Individual investor (minimum)	1	1,200	₹1,21,200
HNI (minimum)	2	2,400	₹2,42,400

At ₹101 a share. In SME IPOs individuals must bid for at least 1 lots.

Subscription

Investor category	Shares bid for
Institutions (QIB)	17,19,600
HNI / NII	53,91,600
Retail	1,28,95,200
Total	2,00,06,400

NSE does not publish the shares offered to each category for this issue, so times subscribed cannot be shown. NSE and BSE bids together.

Applications from individual investors

10,746 applications in the individual investors' category.

NSE does not publish the shares set aside for this category for SME issues, so the chance of allotment cannot be worked out exactly. Winners are picked by lottery.

Demand at each price

Top price ₹101	118.21 lakh shares	59.1%
Cut-off final price, whatever it is; mostly retail	79.84 lakh shares	39.9%
Lower prices ₹96–100	2.02 lakh shares	1.0%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date	13 May 2025
Anchor shares	2,11,200
Raised from anchors	₹2.13 cr
Lock-in ends for the first 50% (30 days)	17 Jun 2025
Lock-in ends for the remaining 50% (90 days)	16 Aug 2025

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

	At issue price	Now
Market value	₹112 cr	₹225 cr
P/E (last 12 months' profit)	8.6	17.2

Revenue, last 12 months	₹101 cr
Profit, last 12 months	₹13 cr
Return on equity	–
Debt to equity	–

From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

Company	Listed	Subscribed	On listing	Since IPO
Bio Medica Laboratories SME	29 May	–	-20.00%	+4.57%
KRM Ayurveda SME	29 Jan	–	+27.48%	+68.89%
Curis Lifesciences SME	14 Nov	–	+14.14%	+38.36%
Influx Healthtech SME	25 Jun	–	+38.02%	+161.46%
Sat Kartar Shopping SME	17 Jan	–	+90.00%	+74.32%
ONYX BIOTEC SME	22 Nov	–	-11.39%	-43.28%

IPO details

Price band	₹96–101
Final issue price	₹101
Lot size	1200 shares
Minimum investment	₹1,21,200 (1 lot)
Market	NSE Emerge (SME)
Issue type	100 % Book Building
Face value	₹10
Industry	Pharmaceuticals
Issue size	Initial public offer of up to 29,46,000 equity shares (including Market Maker portion of 1,47,600 equity shares and anchor portion of 2,11,200 Equity Shares)
ISIN	INE0T8T01010
Registrar	Kfin Technologies Limited Helpline: +91 40 6716 2222, 18003094001, sil.ipo@kfintech.com
Lead managers	Jawa Capital Services Private Limited
Prospectus	Red herring prospectus (NSE)

Check allotment status

Allotment was finalised on 19 May 2025. Check it on the registrar's page (Kfin Technologies Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Accretion Pharmaceuticals IPO price band and lot size?

The price band is ₹96–101 per share, and one lot is 1200 shares (₹1,21,200 at the upper price).

When is the Accretion Pharmaceuticals IPO allotment date?

Allotment was finalised on 19 May 2025, the next working day after bidding closed on 16 May 2025.

How many times was the Accretion Pharmaceuticals IPO subscribed?

Subscription figures are not available yet.

What is the Accretion Pharmaceuticals IPO listing date?

It listed on 21 May 2025 on NSE Emerge (SME).

When does the Accretion Pharmaceuticals anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 17 Jun 2025 and the 90-day lock-in on the rest ends on 16 Aug 2025; they can sell from the next trading day.

What was the Accretion Pharmaceuticals listing gain?

It opened at ₹79.00 against an issue price of ₹101, a loss of 21.78%. It is now up 100.50% from the issue price.